Tag - kidney disease

Kidney disease means your kidneys are damaged and can’t filter blood the way they should. Those with diabetes or high blood pressure are at greater risk of developing kidney disease.

Kidney problems include acute kidney injury, chronic kidney disease, kidney cysts, kidney stones, and kidney infections.

Research in action: How ISN committees are driving the future of kidney research — and how you can be part of it 

Across the ISN’s research groups and committees, this year has been defined by one theme: Turning global collaboration into real-world impact. From uncovering the drivers of chronic kidney disease of unknown origin (CKDu) to strengthening renal registries and shaping the next wave of clinical trials, these groups have been steadily building momentum — work...

Rethinking kidney trials: The ISN’s PARADIGM roadmap moves into action 

  Kidney disease research is entering a pivotal moment. Kidney International®  published the ISN PARADIGM paper, “Changing paradigms of studies in kidney diseases,” outlining a global roadmap to modernize how kidney trials are designed and conducted — with patients, equity, and real-world relevance at the center.   Read the article  What the PARADIGM paper delivers  The article is based...

Turning clinical experience into shared knowledge: ISN launches Kidney International Case ReportsTM

 The ISN has launched Kidney International Case ReportsTM (KICR), a new open-access, peer-reviewed journal dedicated to high-quality case reports, focused reviews, and short clinical communications relevant to kidney care. The publication is led by Editor-in-Chief Swapnil Hiremath (University of Ottawa, Canada) and Deputy Editor Arvind Conjeevaram (Trustwell Hospitals, Bengaluru, India).  KICR is now accepting submissions....

From implementing global kidney health commitments to results of the Phase 2 ACTION2 trial: Read the latest ISN Journal summaries  

Kidney International®   Implementing the commitments of the WHO Kidney Health Resolution: Initial steps in three diverse settings  Chronic kidney disease (CKD) affects 850 million people globally, with the highest burden in low- and middle-income countries. The WHA78 kidney health resolution offers a unique opportunity to advance prevention and care.   This editorial presents case studies from Guatemala, Thailand,...

Stay engaged with the ISN in 2026 – join or renew your ISN membership 

ISN membership runs from January to December — renew now to enjoy uninterrupted access in 2026!  Through MYISN, members can access hundreds of hours of multi-lingual educational content at ISN Academy, explore the Kidney International®  and Kidney International Reports® archives online, and use the member directory to connect with colleagues across regions.   ISN membership also offers:   Reduced...

Advancing kidney care through global partnerships and collaboration: WCN’26 joint sessions 

Kidney care challenges vary from region to region, but the drive to find solutions is universal. WCN'26 joint sessions bring together global partners to present diverse experiences and practical insights to advance best practices in kidney care and improve patient outcomes, no matter where they live.   Explore WCN’26 joint sessions  Discover a selection of standout sessions...

Nearly 2,000 early-career nephrologists choose ISN membership – become part of the ISN global community!

Across all 10 ISN regions, hundreds of early-career nephrologists have chosen the ISN as their global professional home.   ISN Trainee memberships offer one year of free membership followed by three years at a reduced price so that early-career kidney care professionals globally can access career-building opportunities and a collaborative network of peers.  Choose the membership option...

“Are your kidneys healthy?” quiz reaches 32 languages with new Swahili version 

The ISN “Are Your Kidneys Healthy?” quiz is now available in Swahili!  These quick and informative questions, offered in 32 languages, help individuals assess their risk of kidney disease and take proactive steps for kidney health.  If you would like to contribute by translating the quiz into another language, please contact Romane at rblondel@theisn.org.  

ISN around the world: Celebrating excellence and education at global events 

ISN leaders are spotlighting global kidney health in the Middle East in November and in North and East Asia, Western Europe, and South Asia throughout December, and celebrating two 2025 ISN Pioneer Award winners.  By sharing research, building partnerships, and amplifying regional voices, these engagements help advance the global conversation on equitable kidney care.   November 19th Congress of Asian Society of Transplantation (CAST 2025)    November 26-29, 2025                Zahra, Kuwait    November 28, Time TBD (Arabian Standard Time)   A highlight...

Welcoming new ISN Fellows, IN Scholars, and Clinical Research grantees  

From improving transplant outcomes to advancing clinical nephrology in local hospitals, the latest ISN Fellows, Interventional Nephrology (IN) Scholars, and Clinical Research Program grantees are already poised to make a difference in their communities. Through hands-on training, education, and innovative research, these professionals will gain the skills to strengthen worldwide kidney care where it’s...

ISN SGLT2i Toolkit now available in German and Spanish – French coming soon! 

Want quick, reliable references to guide multidisciplinary treatment decisions? The ISN Optimization of SGLT2i Therapy Toolkit provides handy infographics designed to help nephrologists, cardiologists, and other healthcare professionals optimize patient care across kidney, heart, and metabolic conditions.  Access the tools in English, German, and Spanish   Key topics covered include:  Nuts and bolts of SGLT2i therapy at the...

By young nephrologists, for young nephrologists: Research interpretation course now CME-accredited 

By YNC Chair Bianca Davidson  Do you sometimes feel unsure when reading clinical research papers or meta-analyses? You’re not alone — recent surveys show that one of the biggest challenges reported by young nephrologists was limited training in research interpretation.   That’s where the ISN Young Nephrologists Capacity Building Committee steps in. To support early-career professionals, the...

Sydney Tang, SPWG chair, on the global voices, groundbreaking science, and real-world impact of the WCN’26 scientific program

By bringing together experts from diverse regions and disciplines, the WCN’26 Scientific Program Working Group (SPWG) ensures that the World Congress of Nephrology (WCN) delivers scientific content that is of the highest quality and globally representative. We spoke with Sydney Tang, WCN’26 SPWG chair, to explore the many facets of next year’s scientific program,...

ISN Journal summaries on kidney transplantation in patients with plasma cell dyscrasia and gender differences in living kidney donation 

Kidney International®   Management recommendations for kidney transplantation in patients with plasma cell dyscrasia  Patients with plasma cell dyscrasia such as multiple myeloma and AL amyloidosis often develop kidney failure but have been underrepresented in kidney transplantation due to recurrence risk and poor outcomes. A multidisciplinary panel reviewed new evidence showing improved survival with modern therapies and expanding transplant eligibility....

Become a Fellow of the ISN: Recognition for long-term dedication  

 The Fellow of the ISN (FISN) status recognizes sustained dedication to the global kidney community and the ISN’s mission. It highlights a strong commitment to advancing kidney care, mentoring the next generation of nephrologists, and making a lasting impact on global kidney health   Awardees come from every corner of the globe — in 2025, 28% were from Western...

ISN Journal summaries on felzartamab for IgA nephropathy and a new anti-podocin ELISA  

Kidney International®   Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy  A phase 2a trial tested felzartamab, an anti-CD38 antibody, in 54 patients with IgA nephropathy. Patients received different doses of felzartamab or placebo over six months.   Felzartamab reduced protein in the urine, with the strongest and longest-lasting effect seen...

Encouraging government action in Tajikistan: Implementing the ISN Dialysis Framework 

    The deputy minister of health and staff from the Health Department, Tajikistan, visit a new hemodialysis center opened with support from the ISN SRC Program   Irma Tchokhonelidze observed significant gaps in dialysis provision during her 2021 visits to kidney centers in Dushanbe, including limited diagnostic capacity, the absence of patient registries, and inconsistent follow-up...

ISN International Expert Forum: Harnessing multidisciplinary insight for better CKM outcomes 

In October, 77 leading experts gathered in Amsterdam for the “ISN International Expert Forum: Exploring the Nexus of Cardio-Kidney-Metabolic Health,” a multidisciplinary meeting dedicated to shaping the future of cardio-kidney-metabolic (CKM) care.   Over one and a half days of dynamic discussion, participants explored ways to overcome barriers in care delivery, strengthen health system integration,...

HRH Prince Daniel of Sweden meets ISN Immediate Past-President, Masaomi Nangaku, in Japan to champion global kidney health 

On October 14, 2025, His Royal Highness Prince Daniel of Sweden visited ISN Immediate Past-President Masaomi Nangaku at the University of Tokyo Graduate School of Medicine. A kidney transplant recipient and patron of the ISN, Prince Daniel has long been an advocate for kidney disease awareness. They discussed ISN initiatives, including the Global Kidney Health...

ISN Train-the-Trainer Program for pregnancy and kidney disease comes full circle as former trainees join the faculty 

A new cohort of trainees has been accepted into the program and will receive guidance from members of the inaugural cohort, now serving as faculty alongside senior mentors.   The ISN Train-the-Trainer program in pregnancy and kidney diseases, led by Shilpa Jesudason (Australia) and Michelle Hladunewich (Canada), aims to build a robust network of professionals...